Associated Press (AP), the arbiters of style for journalism, issued new rules related to global warming and climate change coverage, infuriating liberal environmentalists.
Their anger stemmed from AP’s guidance which said to use the label “climate change doubters” or “those who reject mainstream climate science” when discussing those that do not accept man-made climate change, rather than “skeptics” or “deniers.”
The left is up in arms over the pharmaceutical CEO who raised prices for a drug mostly used by AIDS patients by more than 5,000 percent, but experts CNBC interviewed said regulatory barriers helped make it possible.
Founder and CEO of Turing Pharmaceutical, Martin Shkreli bought the generic drug Daraprim, which is used for parasitic infections in pregnant women and immunocompromised individuals. He hiked its cost from $13.50 a pill to $750, a whopping 5,455 percent.
Green bullies are at it again, this time trying to shame museums into dropping conservative philanthropist David Koch and his money.
A group of alarmist scientists wrote an open letter claiming museums like the Smithsonian’s Museums of Science and Natural History in Washington, D.C., and the American Museum of Natural History in New York City have compromised their “integrity” by accepting money from him.
Two of the leading lights of the lefty blogosphere weighed in Tuesday on the Bowe Bergdahl matter. Daily Kos founder and publisher Markos Moulitsas, who served a three-year stint in the Army just after graduating from high school, blasted the anti-Bergdahl rhetoric of bloodyhanded neoconservative "chickenhawks" who aren't ashamed to opine despite being "wrong about everything in the last decade."
Kos claimed that since the Afghan war "is now over," the five Taliban exchanged for Bergdahl had to be released anyway "under international law." From Moulitsas's post (emphasis added):